Mylan Pharmaceuticals

Rediff.com » News » Mylan Pharmaceuticals

News for Mylan Pharmaceuticals

News
Business

Govt waives import duty on Remdesivir

Amid surging COVID-19 cases in the country, the government on Tuesday waived customs duty on Remdesivir, its raw materials and other components used to make the antiviral drug. The move would help......

3 lakh remdesivir to be produced daily in 15 days: Govt

The government plans to double the production of antiviral drug remdesivir to around 3 lakh vials per day over the next 15 days, to make it available readily for the treatment of COVID-19.......

5 more manufacturers to produce black fungus drug: Govt

The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing......

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With more drugmakers in line to launch the drug soon, the prices may see a further erosion. Sohini Das reports. IMAGE: An......

India-made Remdesivir may come out in 10 days

The antiviral drug may cost around Rs 55,000 for an 11-dose course, or Rs 5,000 per injection -- much less than the price of imports from Bangladesh, reports Sohini Das. Image used for......

US ruling to hit Indian drug exports

The US Food and Drug Administration has recently taken significant steps to promote "authorised generics" produced under licence from the patent holder, a big pharmaceutical company in most cases.......

Biocon pitches for global top 3 slot

Biocon was scouting for more strategic alliances and exploring opportunities for outlicensing its biotech drugs under development, as it pitches for a slot among the top three bio-pharmaceutical......

A Mylan win in US court could hit Ranbaxy

Ranbaxy Laboratories Ltd might lose the 180-day opportunity to exclusively sell its generic version of Novartis AG's hypertension drug Diovan if a US district court rules in favour of Mylan, which......

Ranbaxy Lipitor rights: Mylan challenge dismissed

In a major reprieve to Ranbaxy, an American court has dismissed a petition from rival pharmaceutical firm Mylan to challenge the former's exclusive marketing rights over the generic version of......

Big drugmakers step in to develop, import test kits

Cadila, Biocon developing rapid antibody testing kits; Eris, Mylan, Gland importing. Indian pharma majors are gearing up to develop or import testing kits for the novel coronavirus as demand for......

Rediff News

Mylan Pharmaceuticals

News for Mylan Pharmaceuticals

Govt waives import duty on Remdesivir

3 lakh remdesivir to be produced daily in 15 days: Govt

5 more manufacturers to produce black fungus drug: Govt

Cipla to price Remdesivir for Covid-19 under Rs 5,000

India-made Remdesivir may come out in 10 days

US ruling to hit Indian drug exports

Biocon pitches for global top 3 slot

A Mylan win in US court could hit Ranbaxy

Ranbaxy Lipitor rights: Mylan challenge dismissed

Big drugmakers step in to develop, import test kits

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS